Abstract
Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Current Medicinal Chemistry
Title: Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection
Volume: 11 Issue: 4
Author(s): John D. Noti
Affiliation:
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Abstract: Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Export Options
About this article
Cite this article as:
Noti D. John, Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection, Current Medicinal Chemistry 2004; 11 (4) . https://dx.doi.org/10.2174/0929867043455945
DOI https://dx.doi.org/10.2174/0929867043455945 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde
Current Cancer Drug Targets The Potential Protective Effect of Orange Peel and Selenium against 17β-Estradiol- Induced Chronic Non-Bacterial Prostatitis in Rats
Anti-Cancer Agents in Medicinal Chemistry Propofol Pharmacokinetics in Patients with Obstructive Jaundice
Current Drug Delivery Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway
Current Hypertension Reviews Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Intravenous Implanted Neural Stem Cells Migrate to Injury Site, Reduce Infarct Volume, and Improve Behavior after Cerebral Ischemia
Current Neurovascular Research Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer
Current Cancer Drug Targets Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases
Current Neuropharmacology Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Recent Patents on CNS Drug Discovery (Discontinued) Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application
Current Vascular Pharmacology Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Inflammatory Caspases: Targets for Novel Therapies
Current Pharmaceutical Design Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Conduction Disorders in the Setting of Acute STEMI
Current Cardiology Reviews Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews The Protective Effects of Levosimendan on Ischemia/Reperfusion Injury and Apoptosis
Recent Patents on Cardiovascular Drug Discovery The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine